Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma

The advent of immune checkpoint (ICP) blockade has introduced an unprecedented paradigm shift in the treatment of cancer. Though very promising, there is still a substantial proportion of patients who do not respond or develop resistance to ICP blockade. In vitro and in vivo models are eagerly neede...

Descripción completa

Detalles Bibliográficos
Autores principales: Castella, Barbara, Melaccio, Assunta, Foglietta, Myriam, Riganti, Chiara, Massaia, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232124/
https://www.ncbi.nlm.nih.gov/pubmed/30460198
http://dx.doi.org/10.3389/fonc.2018.00508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232124/
https://www.ncbi.nlm.nih.gov/pubmed/30460198
http://dx.doi.org/10.3389/fonc.2018.00508

Ejemplares similares